Clinical trials
Phase 4 Dyslipidemias trials in South Korea
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
21 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2007 | 1 |
| 2008 | 1 |
| 2014 | 1 |
| 2015 | 2 |
| 2016 | 1 |
| 2017 | 1 |
| 2018 | 2 |
| 2019 | 4 |
| 2020 | 1 |
| 2022 | 2 |
| 2023 | 4 |
| 2024 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 12 |
| Recruiting | 4 |
| Unknown status | 4 |
| Active, not recruiting | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Yonsei University | 6 |
| Seoul National University Bundang Hospital | 3 |
| Korea University Anam Hospital | 2 |
| Seoul National University Hospital | 2 |
| Yuhan Corporation | 2 |
| Daewon Pharmaceutical Co., Ltd. | 1 |
| Daewoong Pharmaceutical Co. LTD. | 1 |
| Hyo-Soo Kim | 1 |
| Pfizer's Upjohn has merged with Mylan to form Viatris Inc. | 1 |
| Saint Vincent's Hospital, Korea | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Dyslipidemias | 21 |
| Hypertension | 5 |
| Atherosclerosis | 3 |
| Coronary Artery Disease | 3 |
| Diabetes Mellitus, Type 2 | 3 |
| Cardiovascular Diseases | 2 |
| Hypercholesterolemia | 2 |
| Coronary Disease | 1 |
| Diabetes Mellitus | 1 |
| Endocrine System Diseases | 1 |
Trials
Showing 1 to 21 of 21. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.